home / stock / ckdxf / ckdxf short
Short Information | Opthea Ltd (OTCMKTS:CKDXF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 30,130 |
Total Actual Volume | 30,130 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 2 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,507 |
Average Short Percentage | 10.00% |
Is there a CKDXF Short Squeeze or Breakout about to happen?
See the CKDXF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-14-2023 | $0.29 | $0.29 | $0.29 | $0.29 | 130 | 130 | 100% |
06-01-2023 | $0.41 | $0.42 | $0.42 | $0.41 | 30,000 | 30,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Opthea Ltd Company Name:
CKDXF Stock Symbol:
OTCMKTS Market:
MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, includ...
MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, incl...
MELBOURNE, Australia and PRINCETON, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, incl...